Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate)
Lindsey Sattler, Stephen B. Hanauer, Lisa Malter
Topics & Concepts
MedicineAzathioprineInflammatory bowel diseaseTumor necrosis factor alphaCombination therapyInfliximabPharmacologyInternal medicineImmunologyDiseaseInflammatory Bowel DiseaseImmunodeficiency and Autoimmune DisordersSystemic Lupus Erythematosus Research